Ara
Toplam kayıt 14, listelenen: 1-10
Piperlongumine increases the apoptotic effect of doxorubicin and paclitaxel in a cervical cancer cell line
(Wolters Kluwer Medknow Publications, 2020)
Objective: Piperlongumine (PL) is an alkaloid derived from the edible pepper (Piper longum L) and it has been described to have various biologic activities including anticancer effects. Our aim in this study was to assess ...
Causes of Elevated Levels of Serum CA 19.9 in Patients without Prior Diagnosis of Malignant Disease
(2019)
Objective: Serum CA 19.9 is commonly used as a tumor marker for diagnosis and followup of gastrointestinal malignancies. However, elevated levels can be found in various clinicalconditions.Methods: A total of 285 patients ...
In vitro culture of tumor infiltrating lymphocytes for adoptive immunotherapy in breast cancer patients
(Elsevier Sci Ltd, 2018)
[No Abstract Available]
Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting
(Dove Medical Press Ltd, 2016)
Purpose: Antihormonal treatment is an effective therapy in the adjuvant setting. However, musculoskeletal pain is a common adverse effect encountered in patients receiving this treatment. We aimed to evaluate the risk ...
Serum Tumor Marker Levels in Rheumatoid Arthritis
(2016)
Giriş ve Amaç: Romatoid Artrit (RA) eklemleri etkileyen ve görece sık rastlanılan inflamatuar bir hastalıktır. Bu çalışmada RA tanılı hastalarda serum tümör belirteçleri olan karsinoembriyonik antijeni (CEA) ,CA 125, CA ...
Next generation sequencing analysis of BRCA1 and BRCA2 identifies novel variations in breast cancer
(Elsevier Inc., 2020)
Mutations in two major breast cancer susceptibility genes, BRCA1 and BRCA2, have been identified to be the most important predisposing factors for the development of breast cancer. Thus, BRCA1/2 testing is a well-established ...
Predictors of Outcome in Patients with Advanced Nonseminomatous Germ Cell Testicular Tumors
(Asian Pacific Organization Cancer Prevention, 2014)
Background: Predictor factors determining complete response to treatment are still not clearly defined. We aimed to evaluate clinicopathological features, risk factors, treatment responses, and survival analysis of patient ...
Salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology
(Asian Pacific Organization Cancer Prevention, 2013)
Background: We aimed to evaluate prognostic factors and response rates to various treatment approaches to patients with synovial sarcoma in an advanced setting. Materials and Methods: We retrospectively reviewed the medical ...
Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy
(Dove Medical Press Ltd, 2016)
Recurrent squamous cell carcinoma of the skin is a rare but difficult to treat condition. Frequently, the disease presents itself in elderly patients with poor performance status and bearing many comorbidities, thus the ...
Lymphocyte Monocyte Ratio as a Prognostic Factor in Non-Small Cell Lung Cancer
(Elsevier Science Inc, 2017)
[No Abstract Available]